Trial Profile
Randomized, multicentre, open clinical trial assessing the effectiveness and safety of simplification to atazanavir + ritonavir versus continuation of a stable antiretroviral regimen on lopinavir/ritonavir
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Aug 2009
Price :
$35
*
At a glance
- Drugs Atazanavir (Primary) ; Lopinavir/ritonavir (Primary) ; Ritonavir (Primary)
- Indications HIV infections; HIV-1 infections
- Focus Therapeutic Use
- Acronyms ATAZIP
- Sponsors Bristol-Myers Squibb
- 09 Nov 2008 Status changed to completed according to results presented at the 9th International Congress on Drug Therapy in HIV Infection.
- 09 Nov 2008 Results were presented at the 9th International Congress on Drug Therapy in HIV Infection.
- 07 Feb 2006 New trial record.